Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Life Sciences Tools & Services1.51%+0.00 ppBiotechnology3.38%+0.00 ppHealth Care Equipment2.83%+0.00 ppHealth Care Supplies0.14%+0.00 ppPharmaceuticals5.50%+0.00 ppHealth Care Distributors0.51%+0.00 ppHealth Care Services0.71%+0.00 ppManaged Health Care1.95%+0.00 ppHealth Care Facilities0.20%+0.00 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
3.38%
Industry change · 12M
+0.00 pp
Biotechnology · contribution
+0.000 pp
Company participation
0%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Jan 2018 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $179.2bn | 1.022% | +0.000 pp | +0.000 pp | +0.0% | No |
| Amgen → AMGN | United States | $135.1bn | 0.770% | +0.000 pp | +0.000 pp | +0.0% | No |
| Gilead Sciences → GILD | United States | $109.5bn | 0.624% | +0.000 pp | +0.000 pp | +0.0% | No |
| Biogen → BIIB | United States | $73.6bn | 0.420% | +0.000 pp | +0.000 pp | +0.0% | No |
| Vertex Pharmaceuticals → VRTX | United States | $42.2bn | 0.241% | +0.000 pp | +0.000 pp | +0.0% | No |
| Regeneron Pharmaceuticals → REGN | United States | $34.4bn | 0.196% | +0.000 pp | +0.000 pp | +0.0% | No |
| Incyte → INCY | United States | $19.1bn | 0.109% | +0.000 pp | +0.000 pp | +0.0% | No |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.